Baucus Reform Framework Not So Taxing On Industry; $23 Bil. Is Fee-Based
Executive Summary
Senate Finance Committee Chairman Max Baucus' health care reform legislative framework includes a new proposal to raise revenue from the pharmaceutical industry - a $2.3 billion annual fee based on market share
You may also be interested in...
Donut Hole Discounts Would Cost Medicare $17.4 Bil.; AARP Wants Phase Out
The pharmaceutical industry proposal to provide 50 percent discounts on the price of branded drugs for Medicare Part D beneficiaries in the donut hole would wind up costing the federal government $17.4 billion over 10 years, according to estimates by the Congressional Budget Office and the Joint Committee on Taxation released Sept. 16
Donut Hole Discounts Would Cost Medicare $17.4 Bil.; AARP Wants Phase Out
The pharmaceutical industry proposal to provide 50 percent discounts on the price of branded drugs for Medicare Part D beneficiaries in the donut hole would wind up costing the federal government $17.4 billion over 10 years, according to estimates by the Congressional Budget Office and the Joint Committee on Taxation released Sept. 16
Baucus' Donut Hole Drug Discount Plan Would End Up Costing Medicare $17 Bil. Over 10 Years - CBO
Budget office score details costs and savings to Medicare under Sen. Baucus' "chairman's mark" of health reform legislation; discount's cost to pharma is twice as much.